期刊文献+

急性ST段抬高型心肌梗死的治疗策略

下载PDF
导出
摘要 急性ST段抬高型心肌梗死(STEMI)是由于冠状动脉粥样硬化斑块破裂、激活血小板和凝血过程而使冠状动脉血栓性完全阻塞引发的心肌细胞缺血性坏死。早期、持续、有效的心肌再灌注治疗是STEMI的首选治疗方式,明显缩小心肌梗死(MI)面积,挽救心功能,显著改善临床预后。近年,随着对急性心肌梗死(AMI)再灌注治疗策略认识的提高和辅助治疗手段的不断发展,STEMI 12h内再灌注治疗成功率提高40%,院内和30d病死率降低50%。
作者 沈卫峰 沈杰
出处 《内科理论与实践》 2006年第2期76-79,共4页 Journal of Internal Medicine Concepts & Practice
基金 上海市科委重大项目基金资助(N0.05DZ19503)
  • 相关文献

参考文献21

  • 1GUSTO V Investigators.Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprorein Ⅱb/Ⅲa inhibition:the GUSTO V randomised trial[J],2001(9272).
  • 2Huber K;De Caterina R;Kristensen SD.Pre-hospital reperfusion therapy:a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction[J],2005(19).
  • 3van de Weff F;Ardissino D;Betriu A.Management of acute myocardial infarction in patients presenting with ST-segment elevation.The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology[J],2003(01).
  • 4Ellis SG;Da Silva ER;Spaulding CM.Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction:insights from the RESCUE Ⅰ,RESCUE Ⅱ,and other contemporary clinical experiences[J],2000(06).
  • 5Keeley EC;Boura JA;Grines CL.Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction:a quantitative review of 23 randomised trials[J]The Lancet,2003(9351):13-20.
  • 6ZHANG Qi ZHANG Rui-yan ZHANG Jian-sheng HU Jian YANG Zhen-kun NI Jun FANG Yue-hua ZHANG Xian SHEN Wei-feng.One-year clinical outcomes of Chinese sirolimus-eluting stent in the treatment of unselected patients with coronary artery disease[J].Chinese Medical Journal,2006(2):165-168. 被引量:23
  • 7Park CB;Lee CW;Lee BK.Safety and efficacy with drug-eluting stent in ST-segment elevation and non-ST-segment elevation myocardial infarction[J],2006(05).
  • 8Bassand JP;Danchin N;Filippatos G.Implementation of reperfusion therapy in acute myocardial infarction.A policy statement from the European Society of Cardiology[J],2005(24).
  • 9Hahn SA;Chandler C.Diagnosis and management of ST elevation myocardial infarction:a review of the recent literature and practice guidelines,2006(01).
  • 10Silber S;Albertsson P;Aviles FF.Guidelines for percutaneous coronary interventions.The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology[J],2005(08).

二级参考文献46

  • 1沈杰,沈卫峰.替罗非班在急性冠脉综合征介入治疗中的应用[J].国际心血管病杂志,2006,33(3):156-159. 被引量:72
  • 2[1]Elmouchi DA,Bates ER.Platelet glycoprotein Ⅱb/Ⅲa inhibitor therapy in non-ST segment elevation acute coronary syndromes[J].Minerva Cardioangiol,2003,51 (5):547-560.
  • 3[2]Valgimigli M,Percoco G,Malagutti P,et al.Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction:a randomized trial[J].JAMA,2005,293 (17):2109-2117.
  • 4[3]Heitzer,T Ollmann,I Koke,K et al.Platelet Glycoprotein Ⅱb/Ⅲa Receptor Blockade Improves Vascular Nitric Oxide Bioavailability in Patients With Coronary Artery Disease[J].Circulation,2003,108 (5):536-541.
  • 5[4]Warnholtz A,Ostad MA,Heitzer T,et al.Effect of tirofiban on percutaneous coronary intervention-induced endothelial dysfunction in patients with stable coronary artery disease[J].Am J Cardiol,2005,95 (1):20-23
  • 6[5]De Luca G,Smit JJ,Ernst N,et al.Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction[J].Thromb Haemost,2005,93 (5):820-823.
  • 7[6]Martinez-Rios MA,Rosas M,Gonzalez H,et al.Comparison of reperfusion regimens with or without tirofiban in STelevation acute myocardial infarction[J].Am J Cardiol,2004,93 (3):280-287.
  • 8[7]Lavi S,Gruberg L,Kapeliovich M,et al.The impact of GP Ⅱb/Ⅲa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients[J].J Invasive Cardiol,2005,17 (6):296-299.
  • 9[8]Roffi M,Chew DP,Mukherjee D,et al.Platelet glycoprotein Ⅱb/Ⅲa inhibition in acute coronary syndromes.Gradient of benefit related to the revascularization strategy[J].Eur Heart J,2002,23 (18):1441-1448.
  • 10[9]Sabatine MS,Morrow DA,Giugliano RP,et al.Implications of upstream glycoprotein Ⅱb/Ⅲa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction:a comparison of the Thrombolysis In Myocardial Infarction (TIMI) ⅢB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial[J].Circulation,2004,109 (7):874-880.

共引文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部